Physician
Wood, Edmond
Wood, Edmond was paid $105K by Medicaid between Jan 2018 and Oct 2019, across 30 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 54% of everything it billed.
33Billing provider infoWOOD, EDMOND
NEW ORLEANS, LA 70127
NEW ORLEANS, LA 70127
33aNPI1356321004assigned 01/19/2006
33bProvider typeEmergency Medicine Physician
28Total paid$105K
24GClaims3,919
24DCodes billed30
24AFirst – last monthJan 2018 – Oct 2019
Compared with peers
Next to other Emergency Medicine Physician providers in Louisiana
Rank by total paid#62 of 101
Median peer was paid$227K
This provider vs. median0.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,405 | $53K | |
| 2019 | 1,514 | $52K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 54% | 1,091 | 896 | $56K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 20% | 565 | 488 | $21K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7.4% | 156 | 127 | $8K |
| 94060 | 4.0% | 128 | 107 | $4K | |
| 80050 | General health panel | 3.1% | 121 | 106 | $3K |
| 80061 | Lipid panel | 1.5% | 162 | 141 | $2K |
| 93000 | 1.2% | 134 | 99 | $1K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.1% | 13 | 12 | $1K |
| 20610 | <1% | 87 | 15 | $1K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 27 | 14 | $949.39 |
| 64450 | <1% | 30 | 15 | $706.75 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 29 | 27 | $655.50 |
18 more codes
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 18 | $652.63 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 148 | $601.92 |
| 80053 | Comprehensive metabolic panel | <1% | 60 | $601.64 |
| 82962 | <1% | 259 | $591.30 | |
| 86703 | <1% | 67 | $578.60 | |
| 82043 | <1% | 106 | $501.99 | |
| 97032 | <1% | 16 | $365.57 | |
| 99050 | <1% | 18 | $328.52 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 143 | $285.00 |
| 82570 | <1% | 138 | $247.20 | |
| 82728 | <1% | 12 | $162.60 | |
| 83540 | <1% | 12 | $64.08 | |
| 81003 | <1% | 141 | $60.48 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 35 | $1.60 |
| H0033 | Oral medication administration, direct observation | 0% | 129 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 20 | $0.00 |
| J3490 | Unclassified drugs | 0% | 32 | $0.00 |
| S0077 | Injection, clindamycin phosphate, 300 mg | 0% | 22 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.